These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7636844)

  • 1. Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine.
    Alajarin R; Vaquero JJ; Alvarez-Builla J; Pastor M; Sunkel C; Fau de Casa-Juana M; Priego J; Statkow PR; Sanz-Aparicio J; Fonseca I
    J Med Chem; 1995 Jul; 38(15):2830-41. PubMed ID: 7636844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of two optically active calcium channel antagonists labelled with carbon-11 for in vivo cardiac PET imaging.
    Dollé F; Hinnen F; Valette H; Fuseau C; Duval R; Péglion JL; Crouzel C
    Bioorg Med Chem; 1997 Apr; 5(4):749-64. PubMed ID: 9158874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,4-Dihydropyridine activators in the tiamdipine series.
    Galletti F; Luchowski E; Triggle DJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):157-61. PubMed ID: 2147653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permanently charged chiral 1,4-dihydropyridines: molecular probes of L-type calcium channels. Synthesis and pharmacological characterization of methyl(omega-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists.
    Peri R; Padmanabhan S; Rutledge A; Singh S; Triggle DJ
    J Med Chem; 2000 Jul; 43(15):2906-14. PubMed ID: 10956198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
    Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
    Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone.
    Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P
    Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin 1,4-dihydropyridine derivatives.
    Valenti P; Rampa A; Budriesi R; Bisi A; Chiarini A
    Bioorg Med Chem; 1998 Jun; 6(6):803-10. PubMed ID: 9681146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca2+ channels of smooth muscle, cardiac muscle and neuronal tissues.
    Kwon YW; Zhong Q; Wei XY; Zheng W; Triggle DJ
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):128-36. PubMed ID: 2156174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
    Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
    Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
    Anana RD; Ng H; Howlett SE; Knaus EE
    Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
    Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
    J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[4-(1-methoxycarbonyl-1,4-dihydropyridyl)]-3 ,5- pyridinedicarboxylates.
    Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
    Arch Pharm (Weinheim); 1999 Nov; 332(11):385-8. PubMed ID: 10605379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+ channel inhibition by a new dihydropyridine derivative, S11568, and its enantiomers S12967 and S12968.
    Randle JC; Lombet A; Nagel N; Abraham C; Aptel H; Peglion JL; Renaud JF
    Eur J Pharmacol; 1990 Nov; 190(1-2):85-96. PubMed ID: 1706275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives.
    Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
    J Med Chem; 1989 Oct; 32(10):2381-8. PubMed ID: 2795609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different pharmacological properties of the optical isomers of MN9202, a novel 1,4-dihydropyridine Ca+ channel modulator, in rat ventricular myocytes.
    Li XQ; Cao W; Zeng AG; Yang ZF; Xing B; Dong L; Zhang HF; Mei QB
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):817-25. PubMed ID: 20374262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
    Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
    Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological profile of some chloroxanthone-1, 4-dihydropyridine derivatives.
    Bisi A; Budriesi R; Rampa A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Sep; 46(9):848-51. PubMed ID: 8876931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
    Inglesi M; Nicola M; Magnetti S
    Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships.
    Sircar I; Gregor EK; Anderson KR; Haleen SJ; Shih YH; Weishaar RE; Steffen RP; Pugsley TA; Taylor MD
    J Med Chem; 1991 Jul; 34(7):2248-60. PubMed ID: 2066997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.